Oral Levothyroxine: A Life-Saving Alternative for Myxedema Crisis

An observational study analyzing 12 adult patients (median age 66, 50% female) diagnosed with myxedema coma at a tertiary center between 2011 and 2021 highlights the efficacy of high-dose oral levothyroxine as a viable treatment,... read more